VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | Advances in the risk stratification and treatment of essential thrombocythemia

Srdan Verstovsek, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some insights into how risk stratification has advanced in essential thrombocythemia (ET). Dr Verstovsek first explains the importance of assessing patient risk for thrombosis, and then goes on to discuss how methods of assessing this risk have changed in recent years. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter